592 recalls tagged with “poisoning risk”.
Glenmark Pharmaceuticals Inc. recalls 6,432 bottles of Carvedilol Tablets, USP, 12.5 mg, distributed nationwide in the United States. The recall concerns CGMP deviations and the presence of a nitrosamine impurity above the acceptable intake level. Consumers should stop taking the product and contact Glenmark for guidance.
Hi-Tech Pharmaceuticals recalled 85,950 units of L-Glutamine Ultra Pure Powder distributed to multiple retailers after FDA enforcement over unapproved drug claims. The product’s labeling asserts drug-like benefits without FDA approval. Consumers should not consume the product and should contact Hi-Tech Pharmaceuticals for refund or replacement by mail to 6015-B Unity Drive, Norcross, GA 30071.
Westminster Pharmaceuticals is recalling Metoprolol Tartrate Tablets, 100 mg, 1,000-count bottles distributed nationwide in the United States. The recall concerns CGMP deviations that led to the presence of nitrosamine N-nitroso-metoprolol above the established ADI. Consumers should stop using the product and contact Westminster for guidance.
Hi-Tech Pharmaceuticals recalled Joint-RX, a 600 mcg dietary supplement sold nationwide, after regulators flagged unapproved drug claims. The recall affects 85,950 units shipped to more than 40 states. Consumers should stop using the product and contact the company for refunds or replacements.
Glenmark Pharmaceuticals recalls 14,976 bottles of Carvedilol 25 mg distributed nationwide in the United States after FDA-identified NNCI impurity exceeds limits. The impurity prompted CGMP deviation findings. Consumers should stop taking the drug and contact Glenmark or a healthcare provider for guidance.
Glenmark Pharmaceuticals Inc., USA recalls 17,496 bottles of Carvedilol tablets sold nationwide after NNCI impurity exceeded FDA limits. The recall covers lot numbers 17241257, 17241258, and 17241279 with Exp. Date 06/2026. Consumers should stop using the product and contact Glenmark or their healthcare provider for guidance.
Hi-Tech Pharmaceuticals recalled 85,950 units of the LG Sciences Battle Hardener Platinum Series Complete 6 Week Cycle dietary supplement due to unapproved drug claims. The recall targets states across the U.S. The company is listed as Hi-Tech Pharmaceuticals. The remedy is a refund or replacement after notification by letter.
Hi-Tech Pharmaceuticals recalled 85,950 units of PrimeNutrition PhytoForm Fruits & Greens Formula after FDA enforcement flagged unapproved drug claims and misbranding. The dietary supplement was distributed to 40+ states before the recall was issued on 2025-08-06 and remains active. Consumers should not consume the product and should seek refund or replacement from Hi-Tech Pharmaceuticals.
Hi-Tech Pharmaceuticals recalled 85,950 units of Pine Bark Supplements for unapproved drug claims and misbranding. The FDA enforcement notice lists Hi-Tech Pharmaceuticals, Inc. of Norcross, GA as the marketer. The recall cites unapproved drug claims and misbranding as the reason. Consumers should stop using the product and contact the company for refund or replacement information.
M.O.M Enterprises recalled 85,248 units of Organic BABY bedtime drops sold through Multiple Retailers in 31 states. The product is a liquid dietary supplement for infants aged 4 months and older and may spoil due to yeast contamination. Consumers should not consume the product and should seek a refund or replacement from M.O.M Enterprises, LLC.
Enoxaparin Sodium Injection recall active as of 2025. Cardinal Health and Sandoz Inc. distributed the product in Kansas. Bags labeled 80 mg/0.8 mL contained 30 mg/0.3 mL doses. Health authorities urge immediate stop-use and guidance from providers.
Hospira recalls 49,620 vials of Epinephrine Injection, distributed nationwide in the United States. The recall, active since August 4, 2025, targets vials with NDC 0409-4933-05 and case NDC 0409-4933-10. The hazard is lack of assurance of sterility. Health professionals should stop using the product and contact Pfizer or a healthcare provider for guidance.
FDA-listed recall for Hospira brand 8.4% Sodium Bicarbonate Injection affecting 15,750 vials distributed nationwide. The liable lot LH2671, expiring 11/30/2026, is linked to a lack of assurance of sterility. Healthcare providers and patients should stop use and contact Pfizer for guidance.
Hans Kissle Company recalled 66 units of Red Bliss Potato Salad distributed in MA, RI, CT, NJ and NY. The recall is due to undeclared wheat and a mislabeling that identifies the product as potato salad while the unit contains pasta salad. Consumers should not eat the product and should contact Hans Kissle Company for refund or replacement via email.
B. Braun Medical Inc. recalls 23,100 0.9% Sodium Chloride Injection L 8000 containers nationwide. The recall cites lack of assurance of sterility and potential fluid leakage at a weld site. Stop using immediately and consult a healthcare provider.
DFA Dairy Brands recalls 54 cases (324 containers) of a Friendly's branded frozen dessert due to undeclared wheat and soy. The recall covers product distributed in MD, VA, and PA. Consumers should avoid consumption and contact DFA Dairy Brands for refunds or replacements.
Exela Pharma Sciences recalls 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL, nationwide in the U.S. The recall cites out-of-spec arsenic impurities. Consumers should stop use and contact a healthcare provider. Follow recall notice for guidance and refunds.
A recall is active for Sucralfate Tablets, USP 1 gram distributed by American Health Packaging. The firm filed for Chapter 11 in September 2024, triggering CGMP deviations and questions about product identity, strength, quality and purity. The recall affects 26,992 blister packs distributed nationwide. Stop using the product and contact Amerisource Health Services or your clinician for guidance.
Dynamic Sports Nutrition recalled 1,566 bottles of WINN-50 vanazolol dietary supplement sold nationwide. The FDA-listed recall cites degradation of an ingredient and sub-potent Vitamin B12. Consumers should stop using the product and contact the company for refunds or replacements.
Quallent Pharmaceuticals Health LLC recalls 1,856 bottles of Duloxetine delayed-release capsules due to CGMP deviations and an impurity above FDA interim limits. The recall is active as of August 20, 2025. Patients and providers should stop use and contact Breckenridge Pharmaceutical or a healthcare provider for guidance.